KI
BEAT

Kalmar Investments’s BioTelemetry, Inc. BEAT Stock Holding History

Kalmar Investments’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$5.18M Sell
178,973
-148,860
-45% -$3.69M 1.17% 42
2016
Q4 		$7.33M Sell
327,833
-16,970
-5% -$332K 0.38% 88
2016
Q3 		$6.4M Sell
344,803
-44,370
-11% -$837K 0.29% 104
2016
Q2 		$6.34M Sell
389,173
-9,698
-2% -$143K 0.28% 105
2016
Q1 		$4.66M Buy
398,871
+197,980
+99% +$2.21M 0.19% 114
2015
Q4 		$2.35M Sell
200,891
-164,199
-45% -$2.08M 0.06% 152
2015
Q3 		$4.47M Buy
+365,090
New +$4.65M 0.11% 156

Other funds holding BEAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $149M AUM 39.81% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Kalmar Investments's BEAT Position: Q1 2017 in Review

Kalmar Investments reduced its BioTelemetry, Inc. (BEAT) stake by 45% in Q1 2017, selling an estimated $3.69M and leaving 178,973 shares worth $5.18M. The position accounts for 1.17% of the portfolio, ranked #42.

Kalmar Investments first reported a position in BEAT in Q3 2015 and has held it in 7 quarters since. The position peaked at $7.33M in Q4 2016. 178 funds tracked by Wall St. Rank hold BEAT as of Q1 2017.

  • Kalmar Investments held 178,973 shares of BioTelemetry, Inc. worth $5.18M as of Q1 2017.
  • Kalmar Investments sold 148,860 BioTelemetry, Inc. shares in Q1 2017, an estimated $3.69M.
  • BioTelemetry, Inc. made up 1.17% of Kalmar Investments's portfolio in Q1 2017, its #42 holding.
  • Kalmar Investments first reported a position in BioTelemetry, Inc. in Q3 2015 and has held it in 7 quarters since.
  • Kalmar Investments's BioTelemetry, Inc. position peaked at $7.33M in Q4 2016.
  • 178 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2017.

Based on Kalmar Investments's 13F filing for Q1 2017, filed 26 Apr 2017.